F
Filippo Drago
Researcher at University of Catania
Publications - 588
Citations - 17538
Filippo Drago is an academic researcher from University of Catania. The author has contributed to research in topics: Medicine & Receptor. The author has an hindex of 60, co-authored 545 publications receiving 14410 citations. Previous affiliations of Filippo Drago include University of North Carolina at Chapel Hill & Utrecht University.
Papers
More filters
Journal ArticleDOI
Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.
Giuseppe Grosso,Andrzej Pajak,Stefano Marventano,Sabrina Castellano,Fabio Galvano,Claudio Bucolo,Filippo Drago,Filippo Caraci +7 more
TL;DR: Omega-3 PUFA resulted effective in RCTs on patients with bipolar disorder, whereas no evidence was found for those exploring their efficacy on depressive symptoms in young populations, perinatal depression, primary disease other than depression and healthy subjects.
Journal ArticleDOI
Isoflavones: estrogenic activity, biological effect and bioavailability
TL;DR: The evaluation of isoflavone metabolism and bioavailability is crucial to understanding their biological effects and Lipid-based formulations such as drug incorporation into oils, emulsions and self-microemulsifying formulations have been introduced to increase bioavailability.
Journal ArticleDOI
A cannabinoid link between mitochondria and memory
Etienne Hebert-Chatelain,Etienne Hebert-Chatelain,Etienne Hebert-Chatelain,Tifany Desprez,Tifany Desprez,Roman Serrat,Roman Serrat,Luigi Bellocchio,Luigi Bellocchio,Luigi Bellocchio,Edgar Soria-Gomez,Edgar Soria-Gomez,Arnau Busquets-Garcia,Arnau Busquets-Garcia,Antonio C Pagano Zottola,Antonio C Pagano Zottola,Anna Delamarre,Anna Delamarre,Astrid Cannich,Astrid Cannich,Peggy Vincent,Peggy Vincent,Marjorie Varilh,Marjorie Varilh,Laurie M. Robin,Laurie M. Robin,Geoffrey Terral,Geoffrey Terral,M. Dolores García-Fernández,Michelangelo Colavita,Michelangelo Colavita,Michelangelo Colavita,Wilfrid Mazier,Wilfrid Mazier,Filippo Drago,Nagore Puente,Leire Reguero,Izaskun Elezgarai,Jean-William Dupuy,Daniela Cota,Daniela Cota,Maria-Luz Lopez-Rodriguez,Gabriel Barreda-Gómez,Federico Massa,Federico Massa,Pedro Grandes,Pedro Grandes,Giovanni Benard,Giovanni Benard,Giovanni Marsicano,Giovanni Marsicano +50 more
TL;DR: It is shown that acute cannabinoid-induced memory impairment in mice requires activation of hippocampal mtCB1 receptors, and this data reveal that bioenergetic processes are primary acute regulators of cognitive functions.
Journal ArticleDOI
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs
TL;DR: In a chronic, slow progressing pathological process, such as AD, an early start of treatment enhances the chance of success, it is crucial to have biomarkers for early detection of AD-related brain dysfunction, usable before clinical onset.
Journal ArticleDOI
Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets
TL;DR: The evidence on the common molecular pathways between depression and Alzheimer's disease is examined and these pathways are discussed as new pharmacological targets for the treatment of both major depression and Alzheimers disease.